Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor–Targeted Therapy in Metastatic Colorectal Cancer

The monoclonal antibodies panitumumab and cetuximab that target the epidermal growth factor receptor (EGFR) have expanded the range of treatment options for metastatic colorectal cancer. Initial evaluation of these agents as monotherapy in patients with EGFR-expressing chemotherapy-refractory tumors...

Full description

Saved in:
Bibliographic Details
Main Authors: Siena, Salvatore, Sartore-Bianchi, Andrea, Di Nicolantonio, Federica, Balfour, Julia, Bardelli, Alberto
Format: Artigo
Language:Inglês
Published: Oxford University Press 2009
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2758310/
https://ncbi.nlm.nih.gov/pubmed/19738166
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djp280
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items